Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Toboni

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Oncology Reports|November 4, 2021
New Treatments for Recurrent Uterine CancerMichael D Toboni, Matthew A Powell
Obstetrics and Gynecology|October 11, 2018
Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency SyndromeMichael D Toboni, Kerri S Bevis
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 24, 2018
Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program DatabaseMichael D Toboni, Haller J Smith, Sejong Bae, et al.
Gynecologic Oncology Reports|June 16, 2017
Malignant Brenner tumor associated with a germline <i>BRCA2</i> mutationMichael D Toboni, Haller J Smith, Sarah E Dilley, et al.
Gynecologic Oncology|April 12, 2025
Trends in FDA approvals of gynecologic oncology therapeutics from 2019 to 2024Kaitlyn G Dinkins, Grace M Lee, Rebecca C Arend, et al.
Gynecologic Oncology Reports|April 4, 2024
Management of a complete mole and coexisting fetus in post-dobbs worldJordan Barton Garcia, Angela R Seasely, Damien Roland, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2022
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database studyMichael D Toboni, Alexander Cohen, Zachary L Gentry, et al.
The Oncologist|August 25, 2018
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing ParadigmRebecca C Arend, Michael D Toboni, Allison M Montgomery, et al.
Gynecologic Oncology Reports|June 27, 2025
Venous thromboembolism risk for patients with BMI ≥40 kg/m<sup>2</sup> undergoing robotic surgery for endometrial cancerKaitlyn G Dinkins, Grace M Lee, Peter W Ketch, et al.
Gynecologic Oncology|May 13, 2026
A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcomaKati A Turner, Carson C Edwards, Peter W Ketch, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Oncology Reports|November 4, 2021
New Treatments for Recurrent Uterine CancerMichael D Toboni, Matthew A Powell
Obstetrics and Gynecology|October 11, 2018
Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency SyndromeMichael D Toboni, Kerri S Bevis
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 24, 2018
Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program DatabaseMichael D Toboni, Haller J Smith, Sejong Bae, et al.
Gynecologic Oncology Reports|June 16, 2017
Malignant Brenner tumor associated with a germline <i>BRCA2</i> mutationMichael D Toboni, Haller J Smith, Sarah E Dilley, et al.
Gynecologic Oncology|April 12, 2025
Trends in FDA approvals of gynecologic oncology therapeutics from 2019 to 2024Kaitlyn G Dinkins, Grace M Lee, Rebecca C Arend, et al.
Gynecologic Oncology Reports|April 4, 2024
Management of a complete mole and coexisting fetus in post-dobbs worldJordan Barton Garcia, Angela R Seasely, Damien Roland, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2022
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database studyMichael D Toboni, Alexander Cohen, Zachary L Gentry, et al.
The Oncologist|August 25, 2018
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing ParadigmRebecca C Arend, Michael D Toboni, Allison M Montgomery, et al.
Gynecologic Oncology Reports|June 27, 2025
Venous thromboembolism risk for patients with BMI ≥40 kg/m<sup>2</sup> undergoing robotic surgery for endometrial cancerKaitlyn G Dinkins, Grace M Lee, Peter W Ketch, et al.
Gynecologic Oncology|May 13, 2026
A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcomaKati A Turner, Carson C Edwards, Peter W Ketch, et al.
Pageof 3